Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 study of a novel sublingual insulin formulation in type 1 diabetes mellitus
NL-OMON61559Phase 1Recruiting
- Sponsor
- Sublin
- Start
- Sep 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1 trial of human insulin in diabetes mellitus type 1 (T1D), sponsored by Sublin. Started Sep 2026; status: recruiting.
02
Drugs
human insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on NL-OMON61559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON61559.